Skip to content
Screener

Hinge Health HNGE Stock-Based Comp

Stock-Based Comp at other companies

Teladoc Health logo
Teladoc HealthTDOC
$9.3M-58.4%
Globus Medical logo
Globus MedicalGMED
$13.38M-1.7%
Orthofix Medical Inc. logo
Orthofix Medical Inc.OFIX
$7.74M-1.1%
National Research Corporation logo
National Research CorporationNRC
$7.37M+2,301%
LifeMD, Inc. logo
LifeMD, Inc.LFMD
$1.45M-43.1%
Zimmer Biomet Holdings logo
Zimmer Biomet HoldingsZBH
$24.6M+16.0%

Segments

By segment

See full
Reportable Segment$19.09M-96.8%

Other financials

Income statement

See full
Revenue$212.8M+53.0%
Gross profit$183.9M+88.2%
Operating income$40.4M+107%
Net income$43.7M+108%
EPS (diluted)$0.52+104%

Balance sheet

See full
Cash & equivalents$287.7M+20.4%
Total debt$5.9M-40.9%
Total equity$344.3M+98.1%
Total assets$827.4M+19.3%

Cash flow

See full
Operating cash flow$101.4M+401%
CapEx$123.0K-37.6%
Free cash flow$101.3M+406%

Valuation

See full
Market cap$6.2B+31.2%
Enterprise value$5.91B+31.6%
P/E80.5×
P/S8.6×-1.2×

Profitability

See full
Gross margin84.5%+6.8pp
Operating margin9.2%
Net margin10.7%
FCF margin40.3%+21.3pp

Returns & leverage

See full
Return on equity29.7%
Debt / equity0.0×
Current ratio1.3×-0.6×

Where this comes from

Reported directly by Hinge Health in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensation.

The source filing: Hinge Health’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 4:14 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001628280-26-054327
Line itemSix Months Ended June 30, 2026Six Months Ended June 30, 2025
Net income (loss)$78,818$(558,512)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Depreciation and amortization2,2342,646
Stock-based compensation30,784590,990
Amortization of deferred commissions35,29019,870
Accretion of discounts and amortization of premiums on marketable securities, net704326
Non-cash operating lease expense1,8341,688
Provision for credit losses1,6132,780

Item 1. Financial Statements (Unaudited)

FAQ

What is Hinge Health's stock-based comp?
Hinge Health (HNGE) reported stock-based comp of $19.09M in Q2 2026.
How has Hinge Health's stock-based comp changed year-over-year?
Hinge Health's stock-based comp decreased by 96.8% year-over-year, from $590.98M to $19.09M.
What does stock-based comp mean?
Total non-cash stock-based compensation expense for equity awards (RSUs, options, ESPP), added back to net income in cash flow reconciliation.

Ask your AI about Hinge Health's stock-based comp.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude